Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Nov;64(Suppl 4):iv104–iv105. doi: 10.1136/ard.2005.042515

Toll-like receptor 2 signalling and inflammation

F Liew, M Patel, D Xu
PMCID: PMC1766907  PMID: 16239376

Full Text

The Full Text of this article is available as a PDF (47.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashburner M. Europe must grant crucial funds for biological research. Nature. 1999 Nov 4;402(6757):12–12. doi: 10.1038/46888. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J., Chung K. F., Page C. P. Inflammatory mediators of asthma: an update. Pharmacol Rev. 1998 Dec;50(4):515–596. [PubMed] [Google Scholar]
  3. Brint Elizabeth K., Fitzgerald Katherine A., Smith Philip, Coyle Anthony J., Gutierrez-Ramos Jose-Carlos, Fallon Padraic G., O'Neill Luke A. J. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction. J Biol Chem. 2002 Oct 3;277(51):49205–49211. doi: 10.1074/jbc.M209685200. [DOI] [PubMed] [Google Scholar]
  4. Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994 Aug 26;265(5176):1237–1240. doi: 10.1126/science.7520605. [DOI] [PubMed] [Google Scholar]
  5. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J. E., Roncarolo M. G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997 Oct 16;389(6652):737–742. doi: 10.1038/39614. [DOI] [PubMed] [Google Scholar]
  6. Henderson W. R., Jr, Lu J., Poole K. M., Dietsch G. N., Chi E. Y. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. J Immunol. 2000 Mar 15;164(6):3360–3367. doi: 10.4049/jimmunol.164.6.3360. [DOI] [PubMed] [Google Scholar]
  7. Leadbetter Elizabeth A., Rifkin Ian R., Hohlbaum Andreas M., Beaudette Britte C., Shlomchik Mark J., Marshak-Rothstein Ann. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002 Apr 11;416(6881):603–607. doi: 10.1038/416603a. [DOI] [PubMed] [Google Scholar]
  8. Liu Haiying, Hu Bin, Xu Damo, Liew Foo Y. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol. 2003 Nov 15;171(10):5012–5017. doi: 10.4049/jimmunol.171.10.5012. [DOI] [PubMed] [Google Scholar]
  9. McKeever Tricia M., Lewis Sarah A., Smith Chris, Collins Juliet, Heatlie Heath, Frischer Martin, Hubbard Richard. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol. 2002 Jan;109(1):43–50. doi: 10.1067/mai.2002.121016. [DOI] [PubMed] [Google Scholar]
  10. Redecke Vanessa, Häcker Hans, Datta Sandip K., Fermin Agnes, Pitha Paula M., Broide David H., Raz Eyal. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol. 2004 Mar 1;172(5):2739–2743. doi: 10.4049/jimmunol.172.5.2739. [DOI] [PubMed] [Google Scholar]
  11. Revets Hilde, Pynaert Gwenda, Grooten Johan, De Baetselier Patrick. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol. 2005 Jan 15;174(2):1097–1103. doi: 10.4049/jimmunol.174.2.1097. [DOI] [PubMed] [Google Scholar]
  12. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992 Jan 30;326(5):298–304. doi: 10.1056/NEJM199201303260504. [DOI] [PubMed] [Google Scholar]
  13. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995 Aug 1;155(3):1151–1164. [PubMed] [Google Scholar]
  14. Sieling Peter A., Chung Woosin, Duong Baochau T., Godowski Paul J., Modlin Robert L. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol. 2003 Jan 1;170(1):194–200. doi: 10.4049/jimmunol.170.1.194. [DOI] [PubMed] [Google Scholar]
  15. Takeda Kiyoshi, Kaisho Tsuneyasu, Akira Shizuo. Toll-like receptors. Annu Rev Immunol. 2001 Dec 19;21:335–376. doi: 10.1146/annurev.immunol.21.120601.141126. [DOI] [PubMed] [Google Scholar]
  16. Thoma-Uszynski S., Kiertscher S. M., Ochoa M. T., Bouis D. A., Norgard M. V., Miyake K., Godowski P. J., Roth M. D., Modlin R. L. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol. 2000 Oct 1;165(7):3804–3810. doi: 10.4049/jimmunol.165.7.3804. [DOI] [PubMed] [Google Scholar]
  17. Umetsu Dale T., McIntire Jennifer J., Akbari Omid, Macaubas Claudia, DeKruyff Rosemarie H. Asthma: an epidemic of dysregulated immunity. Nat Immunol. 2002 Aug;3(8):715–720. doi: 10.1038/ni0802-715. [DOI] [PubMed] [Google Scholar]
  18. Velasco German, Campo Monica, Manrique Oscar J., Bellou Abdelouahab, He Hongzhen, Arestides Ruth S. S., Schaub Bianca, Perkins David L., Finn Patricia W. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol. 2004 Dec 2;32(3):218–224. doi: 10.1165/rcmb.2003-0435OC. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES